CEREBROVASCULAR DISEASES
metrics 2024
Innovating treatment strategies for cerebrovascular disorders.
Introduction
CEREBROVASCULAR DISEASES is a prestigious journal published by KARGER that focuses on the critical field of cerebrovascular health, encompassing research and advancements in cardiology and neurology. With a strong emphasis on high-quality, peer-reviewed publications, the journal has established itself as an essential resource since its inception in 1987, contributing to the understanding and management of cerebrovascular disorders. It holds a commendable Q2 ranking across various categories, including Cardiology and Cardiovascular Medicine, which underscores its influence within the research community. The journal is especially significant for professionals and researchers interested in the intersection of neurological and cardiovascular health, facilitating knowledge sharing and innovative research. Although it does not operate under an Open Access model, the journal is well-regarded for its rigorous selection criteria and impactful findings. By continuing to publish cutting-edge research, CEREBROVASCULAR DISEASES aims to foster advancements in treatment and prevention strategies for cerebrovascular diseases, thereby contributing to improved patient outcomes worldwide.
Metrics 2024
Metrics History
Rank 2024
Scopus
IF (Web Of Science)
JCI (Web Of Science)
Quartile History
Similar Journals
CURRENT NEUROVASCULAR RESEARCH
Bridging Neuroscience and Vascular Health for TomorrowCURRENT NEUROVASCULAR RESEARCH is an esteemed peer-reviewed journal published by Bentham Science Publishers Ltd, focusing on the intricate relationships within the realms of cellular and molecular neuroscience, developmental neuroscience, and neurology. With an ISSN of 1567-2026 and an E-ISSN of 1875-5739, this journal has been contributing to the field since its inception in 2004 and is poised to continue through 2024. As a resource dedicated to disseminating innovative research findings, CURRENT NEUROVASCULAR RESEARCH is recognized within Category Quartiles as Q3 in multiple fields, including Neurology (clinical) and Developmental Neuroscience. Although classified in the Q4 category for Cellular and Molecular Neuroscience, the journal maintains a crucial role in fostering academic discourse and advancing our understanding of neurovascular dynamics. Researchers, professionals, and students will find valuable insights in this journal, offering access to a diverse range of studies that highlight cutting-edge developments in the field.
Journal of NeuroInterventional Surgery
Exploring the Intersection of Neurology and Intervention.The Journal of NeuroInterventional Surgery, published by the BMJ Publishing Group, stands at the forefront of advancing knowledge in the fields of neurointerventional procedures, neurology, and surgical techniques. With an impressive impact factor reflective of its high-quality contributions, this journal occupies a prestigious position within the Q1 category across multiple domains: Medicine (miscellaneous), Neurology (clinical), and Surgery, ranking 11th in Medicine Surgery and 47th in Neurology Clinical out of their respective categories per Scopus metrics. Since its inception in 2009, it has provided an essential platform for researchers, clinicians, and students to disseminate innovative findings and engage with groundbreaking developments in neurointerventional practices. As a prominent publication in the United Kingdom, located at British Med Assoc House, it is committed to open communication within the community, fostering collaboration, and setting the stage for future innovations in patient care and outcomes.
Stroke Research and Treatment
Advancing stroke science for better patient outcomes.Stroke Research and Treatment is a premier Open Access journal published by HINDAWI LTD, dedicated to advancing the understanding and management of stroke and related neurological disorders. Since its inception in 2010, this journal has established itself as a valuable resource for researchers and clinicians in the field of neurology, providing a platform for high-quality, peer-reviewed articles that aim to improve patient outcomes and stimulate clinical practice innovations. With a 2023 Scopus ranking placing it in the Q3 category and a percentile ranking of 44th in clinical neurology, the journal is positioned to influence the ongoing discourse in stroke research. Stroke Research and Treatment embraces a global audience, with its editorial operations based in London, England. The journal's commitment to open access ensures that its content is freely available to all, promoting extensive dissemination and engagement in this critical field of study. Researchers, professionals, and students are encouraged to contribute their findings to this dynamic journal, fostering collaboration and knowledge sharing in the ongoing fight against stroke.
Cerebrovascular Diseases Extra
Unlocking Innovations in Cerebrovascular ResearchCerebrovascular Diseases Extra is a distinguished open-access journal published by KARGER, operating out of Switzerland since 2011. With ISSN 1664-5456, this journal aims to bridge the gap in knowledge surrounding cerebrovascular diseases, an essential segment of both Cardiology and Cardiovascular Medicine as well as Neurology. Ranked in the third quartile by Scopus for various categories, including Cardiology, Neurology, and Clinical Neurology, it is specially designed for academics, clinicians, and researchers who seek to disseminate and gain insights into the latest advancements and research findings in these critical areas. By embracing open access, it amplifies the reach and impact of its published research, ensuring that vital information is readily accessible to a global audience. As the journal converges towards its targeted years from 2015 to 2024, it remains a pivotal platform for fostering innovative ideas and collaborative research in cerebrovascular health.
NEUROLOGY
Pioneering insights in the realm of neurology.NEUROLOGY, published by Lippincott Williams & Wilkins, stands as a premier journal in the field of neurology, holding an esteemed Q1 category ranking in clinical neurology as of 2023. Established in 1951, this journal has been a critical resource for the dissemination of cutting-edge research and clinical advancements, with an impressive Scopus rank of 24 out of 400, placing it in the 94th percentile among its peers. NEUROLOGY serves as a vital platform for neurologists, researchers, and medical professionals seeking to stay abreast of the latest findings and innovations in the treatment and understanding of neurological disorders. With its rigorous peer-review process and commitment to excellence, NEUROLOGY remains essential reading for all individuals dedicated to advancing the science and practice of neurology, contributing significantly to the ongoing dialogue in this vital area of medicine.
INTERVENTIONAL NEURORADIOLOGY
Pioneering Research in Neuroradiological InterventionsINTERVENTIONAL NEURORADIOLOGY, published by SAGE PUBLICATIONS INC, is a key journal within the interdisciplinary fields of cardiology, neurology, and radiology, focusing on the latest advancements and clinical practices in neuroradiology. With an ISSN of 1591-0199 and an E-ISSN of 2385-2011, this journal has established itself as a vital resource since its inception in 1996, attracting contributions from leading experts worldwide. Currently categorized in the Q2 category for Cardiology and Cardiovascular Medicine and Radiology, and Q3 for Clinical Neurology as of 2023, INTERVENTIONAL NEURORADIOLOGY has gained recognition for its impactful research, reflected in its ranking within the Scopus metrics. Although not an open-access publication, its rigorous peer-reviewed articles provide indispensable knowledge that enhances the practice and understanding of interventional procedures. Researchers, clinicians, and students will find this journal a valuable avenue for insights into the evolving landscape of neuroradiological interventions, ultimately contributing to improved patient outcomes.
NEUROIMAGING CLINICS OF NORTH AMERICA
Empowering Clinicians with Cutting-Edge Imaging SolutionsNEUROIMAGING CLINICS OF NORTH AMERICA is a premier peer-reviewed journal published by W B SAUNDERS CO-ELSEVIER INC, focusing on the evolving field of neuroimaging and its applications in clinical practice. Established in 1993, this journal has become a pivotal resource for researchers, professionals, and students alike, providing in-depth articles, reviews, and case studies that address both cutting-edge advancements and standard practices in neuroimaging. With its impressive credentials, ranking in the top quartiles of various medical categories—including Q2 in Medicine (Miscellaneous) and Q2 in Radiology, Nuclear Medicine, and Imaging—the journal is vital for advancing knowledge and clinical applications in the disciplines of neurology and radiology. Although it does not offer open access, the journal maintains a robust reputation with a broad readership, embodying a commitment to excellence in medical literature. The ISSN number is 1052-5149 and the E-ISSN number is 1557-9867, ensuring the accessibility and dissemination of high-quality neuroimaging research.
NEUROLOGIST
Bridging Research and Practice in NeurologyNEUROLOGIST, an esteemed journal published by Lippincott Williams & Wilkins, serves as a vital resource in the fields of Neurology and Medicine. With an ISSN of 1074-7931 and an E-ISSN of 2331-2637, this journal has been dedicated to advancing the understanding of neurological disorders since its inception in 1996, with continual contributions through 2024. Achieving a respectable Q3 rank in both Medicine (miscellaneous) and Neurology (clinical), it provides an essential platform for disseminating innovative research and clinical studies. Although it is not an open-access publication, NEUROLOGIST promotes a rich exchange of ideas and findings for researchers, healthcare professionals, and students alike, helping to bridge the gaps in neurological research and practice. The journal is recognized for its commitment to enhancing clinical practice and research methodology, making it a valuable asset for anyone engaged in the dynamic field of neurology.
Stroke and Vascular Neurology
Elevating the standards of vascular neurology.Stroke and Vascular Neurology is a premier open access journal published by BMJ PUBLISHING GROUP, dedicated to advancing the field of vascular neurology and cardiology. With an ISSN of 2059-8688 and an E-ISSN of 2059-8696, the journal has established itself as a leading platform for disseminating cutting-edge research since its transition to open access in 2016. Based in the United Kingdom, at BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND, the journal's outstanding reputation is reflected in its Q1 rankings in both Cardiology and Cardiovascular Medicine and Neurology (clinical) for 2023, placing it in the top tier of its categories. With Scopus rankings of 28 out of 387 in Cardiology and 30 out of 400 in Neurology (clinical), both within the 92nd percentile, Stroke and Vascular Neurology serves as an essential resource for researchers, clinicians, and students looking to stay at the forefront of advancements in the management and understanding of stroke-related disorders. The journal's commitment to high-quality research contributes significantly to improving patient outcomes and shaping the future of vascular health.
ACTA NEUROLOGICA SCANDINAVICA
Advancing Neurological InsightsACTA NEUROLOGICA SCANDINAVICA is a prestigious journal published by Wiley that has significantly contributed to the field of neurology and neuroscience since its inception in 1961. With a broad scope encompassing clinical and experimental research, this journal is esteemed for its rigorous peer-review process and high-quality publications. Located in the United Kingdom, it is recognized in the 2023 category quartiles as Q1 in Medicine (miscellaneous) and Q2 in both Neurology and Clinical Neurology, indicating its strong influence and relevance within the medical community. With an H-index demonstrating consistent citation impact, ACTA NEUROLOGICA SCANDINAVICA holds a Scopus rank of #86 out of 400 in Clinical Neurology, reflecting its contribution to advancing current knowledge and practice. Researchers, professionals, and students alike will find in this journal a valuable resource for the latest findings, discussions, and developments in understanding neurological disorders and treatments, furthering educational and clinical endeavors alike.